ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.09
-0.56%
US Tech 100
20,468.00
-0.92%
S&P 500
5,867.08
-0.09%
US Dollar vs CAD
1.43899
-0.09%
Bitcoin
97,453.67
-0.01%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Immupharma Plc (IMM) Share Price

Immupharma Plc

Immupharma Plc (IMM)

Immutep Limited
International Metals Mining Corp
1.28
0.00
(0.00%)
Closed December 20 10:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
1.28
Bid
1.06
Ask
1.50
Volume
0.00
0.00 Day's Range 0.00
0.83 52 Week Range 2.90
Market Cap
5.33M
Previous Close
1.28
Open
-
Last Trade
(O)
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
1,385,282
Shares Outstanding
416,440,000
Dividend Yield
-
PE Ratio
-1.83
Earnings Per Share (EPS)
-0.01
Revenue
-
Net Profit
-2.92M

About Immupharma Plc

Sector
Finance Services
Industry
Finance Diversified
Website
www.immupharma.com
Headquarters
London, Gbr
Founded
2006
Immupharma Plc is listed in the Finance Services sector of the London Stock Exchange with ticker IMM. The last closing price for Immupharma was 1.28p. Over the last year, Immupharma shares have traded in a share price range of 0.83p to 2.90p.

Immupharma currently has 416,440,000 shares outstanding. The market capitalization of Immupharma is £5.33 million. Immupharma has a price to earnings ratio (PE ratio) of -1.83.

Ask ADVFN Intelligence (AI)

IMM Latest News

More News

Immupharma PLC Holding(s) in Company

Immupharma PLC 10 December 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...

December 10 2024
RNS Regulatory News

Immupharma PLC Appointment of Company Secretary

Immupharma PLC 04 December 2024                                                                                                                                                                  ...

December 04 2024
RNS Regulatory News

ImmuPharma narrows losses in first half as expenses fall

ImmuPharma PLC on Monday expressed optimism about the potential of its pipeline, after narrowing pretax loss in the f ...

September 09 2024
Alliance News

ImmuPharma obtains second warrant extension with Incanthera

ImmuPharma PLC said on Monday it had extended its warrants in Incanthera PLC for the second time, valid now until Mar ...

September 09 2024
Alliance News

Immupharma PLC Extension of Warrants in Incanthera to 31 Mar 2025

Immupharma PLC 09 September 2024                                                                                                                                                                 ...

September 09 2024
RNS Regulatory News

Immupharma PLC Half-year Report

Immupharma PLC 09 September 2024   RNS: RELEASE | 9 September 2024       ImmuPharma PLC ("ImmuPharma" or the "Company")   INTERIM RESULTS for the six months ended 30 June 2024   ImmuPharma PLC...

September 09 2024
RNS Regulatory News

Immupharma PLC Holding(s) in Company

Immupharma PLC 06 August 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...

August 06 2024
RNS Regulatory News

Immupharma PLC Result of AGM

Immupharma PLC 28 June 2024       RNS: RELEASE                                                                                                                                             ...

June 28 2024
RNS Regulatory News

EARNINGS AND TRADING: STV sees advertising upturn; Angle loss narrows

The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not s ...

June 05 2024
Alliance News

Immupharma PLC Notice of AGM & Annual Report & Accounts

Immupharma PLC 05 June 2024           RNS: RELEASE                                                                                                                                              ...

June 05 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.010.7874015748031.271.3651.0212052541.21879379DE
4-0.295-18.73015873021.5751.6150.8523928731.19605656DE
12-0.53-29.28176795581.811.9950.8513852821.40620698DE
26-0.96-42.85714285712.242.30.8513166761.56136685DE
52-0.35-21.4723926381.632.90.8317252741.72993705DE
156-6.12-82.70270270277.49.50.8315970183.1647455DE
260-14.66-91.969887076515.9421.30.8313964125.76948887DE

IMM - Frequently Asked Questions (FAQ)

What is the current Immupharma share price?
The current share price of Immupharma is 1.28p
How many Immupharma shares are in issue?
Immupharma has 416,440,000 shares in issue
What is the market cap of Immupharma?
The market capitalisation of Immupharma is GBP 5.33M
What is the 1 year trading range for Immupharma share price?
Immupharma has traded in the range of 0.83p to 2.90p during the past year
What is the PE ratio of Immupharma?
The price to earnings ratio of Immupharma is -1.83
What is the reporting currency for Immupharma?
Immupharma reports financial results in GBP
What is the latest annual profit for Immupharma?
The latest annual profit of Immupharma is GBP -2.92M
What is the registered address of Immupharma?
The registered address for Immupharma is ONE BARTHOLOMEW CLOSE, LONDON, EC1A 7BL
What is the Immupharma website address?
The website address for Immupharma is www.immupharma.com
Which industry sector does Immupharma operate in?
Immupharma operates in the FINANCE DIVERSIFIED sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
0A2IH World Group Ltd
US$ 0.00
(0.00%)
0
0A2DCrh Plc
US$ 0.00
(0.00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
US$ 0.00
(0.00%)
0
0A22Anheuser Busch Inbev Nv
US$ 0.00
(0.00%)
0
0A1UUber Technologies Inc
US$ 60.85
(0.00%)
1.06k
0A2IH World Group Ltd
US$ 0.00
(0.00%)
0
0A2DCrh Plc
US$ 0.00
(0.00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
US$ 0.00
(0.00%)
0
0A22Anheuser Busch Inbev Nv
US$ 0.00
(0.00%)
0
0A1UUber Technologies Inc
US$ 60.85
(0.00%)
1.06k
0R0XTesla Inc
US$ 437.40
(0.00%)
20.86k
0R24Intel Corp
US$ 19.45
(0.00%)
6.26k
0R1OAmazon.com Inc
US$ 225.50
(0.00%)
3.12k
0R2VApple Inc
US$ 251.50
(0.00%)
2.43k
0HCIAlibaba Group Holding Ltd
US$ 84.70
(0.00%)
2.32k

Discussion

View Full Feed
chereb19 chereb19 13 minutes ago
Isopet has been proven to be profitable
RDGL
QuantumTravesty QuantumTravesty 17 minutes ago
Thanks.
HIRU
knrorrel knrorrel 32 minutes ago
very nice
QNCCF
GASMASK GASMASK 43 minutes ago
What's/who's TA?
MRGE
JerryCampbell JerryCampbell 1 hour ago
Data entry error the previous day.

Someone mistakenly entered 8,000,000 instead of 800,000. The -7.2m corrects it.
NWBO
georgejjl georgejjl 1 hour ago
I guess that Anavex could have sales of $14 billion during the first full year after approval in 2026 by the EMA in the EU alone based on capturing a 25% market share of the 8 million people in the EU with Alzheimer’s disease at a prescription cost of $7,000 per year per patient.

Go
AVXL
jeunke22 jeunke22 1 hour ago
Thanks KCC , I am still very positive about my investment here. Doing business implies to understand when it is time to adapt to a given set of circumstances. No need to try to go through a wall, if you can go around it. I think that is what has changed here. A more practical and energetic way to g
LWLG
DMC8 DMC8 1 hour ago
Feeling burnout recently fellow shareholders?

Watch the youtube chat on how to manage burnout by Patrice Bonfiglio, President of Sarissa Capital Management LP.
https://youtu.be/wpFutxLn-wk?si=6Rm2JhCbHvgvUcsb
AMRN
lodas lodas 1 hour ago
jhdf51........never buy a Put or a Call option unless you are 100% sure of the outcome at expiration.... why? you only a 50% chance of success... said another way... you either win, or lose...... however by Selling a Put, or Call options, you have a 66% chance of winning, or 2 ways out of three...
COOP
pepeoil pepeoil 1 hour ago
Good morning shrimpers. Bwahaaaaaa. We are broke. Lol
THEDOG 17 THEDOG 17 1 hour ago
O and you may as well clock out because Bio was acquired!! Yeah if you can’t figure it out maybe you should read that report eagle just posted!!!! Acquisition!!!!! Let’s gooo
jhdf51 jhdf51 1 hour ago
My bird in the hand is COOP. Escrow is now a ROC
capable of carrying hopeful escrowers in its talons.

JHD
COOP
jhdf51 jhdf51 1 hour ago
It seems that people playing options are like people going to Vegas.. they never lose.

JHD
COOP
2018trader 2018trader 1 hour ago
Just keep buying the monopoly 7, I mean mag 7
SPY
TCI1 TCI1 1 hour ago
I can’t open the link to the CVS coverage for 2025, would like to see it as they dropped Vascepa in July.

Sleven have you seen any positive or negative changes?
CVS
TCI1 TCI1 1 hour ago
Well UHC has both IPE and Vascepa covered with PA so you would hope and expect all CVD indications to go to Vascepa. Not sure if this is a change or not but by using a PA UHC are exposing themselves to litigation if they prioritise generic for CVD. Of course this is based off insurers adhering to th
AMRN
Real McCoy Real McCoy 1 hour ago
Yes. In this case the assets were acquired. A long time ago. Right?
THEDOG 17 THEDOG 17 1 hour ago
Sorry I can read !! Obviously you can’t. Acquisition-is that not a real word?
devil dog 96 devil dog 96 2 hours ago
Their O/S has been unchanged since 2021. These guys protect their share structure + they are great at marketing. Can't wait for them to be ready to fire up their next story. She is setup for some silver with how light they have kept her. Heck she has not had an RS since 2009 like 16 years ago and sh
CRSM
newmedman newmedman 2 hours ago
That's the GOP "man date" ;-)
go seek go seek 2 hours ago
Well, in this game one soon learns that the race is not a sprint. At least that’s my experience. We are all puzzled by the price drop since 24 October. We could debate the drop ad infinitum. I don’t understand it, and probably never will. GLTA
ENTA
Viewmont Viewmont 2 hours ago
It looks like we don't read the news or reports anymore.
They've been yelling that they're getting ready to submit it for FDA approval! LOL.
No need to do any DD, just rely on the next guy.

https://x.com/ADHCMANAGEMENT/status/1866858719339823271
https://x.com/ADH
ADHC
north40000 north40000 2 hours ago
Am I correct that all LTCLs and STCLs currently can be used by either spouse to offset any corresponding LTCGs and STCGs accruing in taxable account(s) in any year before death of either spouse?
AMRN
Remember Tomorrow Remember Tomorrow 2 hours ago
I hate it when I get my Schwartz twisted.

RT
XRPUSD

Your Recent History

LSE
IMM
Immupharma
TSXV
SPC
SPC Nickel
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads